High-Throughput Screening Using a Whole-Cell Virus Replication Reporter Gene Assay to Identify Inhibitory Compounds against Rift Valley Fever Virus Infection

scientific article published on 13 January 2016

High-Throughput Screening Using a Whole-Cell Virus Replication Reporter Gene Assay to Identify Inhibitory Compounds against Rift Valley Fever Virus Infection is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1177/1087057115625184
P698PubMed publication ID26762502
P5875ResearchGate publication ID290444431

P50authorMatthias HabjanQ46151229
Clas AhlmQ56945869
Maria BaudinQ60449515
Christopher T ÖbergQ64682157
P2093author name stringFriedemann Weber
Magnus Evander
Jonas Eriksson
Anna K Överby
Md Koushikul Islam
P2860cites workReverse genetics systems as tools for the development of novel therapies against filovirusesQ38244444
NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinaseQ39195523
T7 RNA polymerase-dependent and -independent systems for cDNA-based rescue of Rift Valley fever virusQ39946457
Development of a reverse genetics system to generate a recombinant Ebola virus Makona expressing a green fluorescent proteinQ40149516
MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screeningQ40983664
Bright far-red fluorescent protein for whole-body imaging.Q50681538
High content image-based screening of a protease inhibitor library reveals compounds broadly active against Rift Valley fever virus and other highly pathogenic RNA virusesQ21144476
A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening AssaysQ28145712
Ribavirin--current status of a broad spectrum antiviral agentQ28190105
Dimethyl sulfoxide promotes the multiple functions of the tumor suppressor HLJ1 through activator protein-1 activation in NSCLC cellsQ28482396
Aerosol exposure to Rift Valley fever virus causes earlier and more severe neuropathology in the murine model, which has important implications for therapeutic developmentQ28486013
Rift valley Fever virus encephalitis is associated with an ineffective systemic immune response and activated T cell infiltration into the CNS in an immunocompetent mouse modelQ28539632
Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylationQ33406230
Risk factors for severe Rift Valley fever infection in Kenya, 2007.Q34034024
Tick-borne encephalitis virus delays interferon induction and hides its double-stranded RNA in intracellular membrane vesiclesQ34055431
Hemorrhagic fever viruses as biological weapons: medical and public health managementQ34126496
MScreen: an integrated compound management and high-throughput screening data storage and analysis system.Q34307121
Favipiravir (T-705), a novel viral RNA polymerase inhibitorQ34374652
A systematic review of Rift Valley Fever epidemiology 1931-2014.Q34487937
Deletion of the NSm virulence gene of Rift Valley fever virus inhibits virus replication in and dissemination from the midgut of Aedes aegypti mosquitoesQ35097798
High-content image-based screening of a signal transduction pathway inhibitor small-molecule library against highly pathogenic RNA virusesQ35363438
NSm protein of Rift Valley fever virus suppresses virus-induced apoptosisQ36315241
Rift Valley fever virus strain MP-12 enters mammalian host cells via caveola-mediated endocytosisQ36397378
Identification of Rift Valley fever virus nucleocapsid protein-RNA binding inhibitors using a high-throughput screening assayQ36462318
Rift valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animalsQ36484009
Ribavirin-induced anemia: mechanisms, risk factors and related targets for future research.Q36683930
Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatmentQ37683496
P433issue4
P921main subjectRift Valley fever virusQ14276794
Rift Valley feverQ326638
Rift Valley fever phlebovirusQ24809101
P304page(s)354-362
P577publication date2016-01-13
P1433published inJournal of Biomolecular ScreeningQ6294856
P1476titleHigh-Throughput Screening Using a Whole-Cell Virus Replication Reporter Gene Assay to Identify Inhibitory Compounds against Rift Valley Fever Virus Infection
P478volume21

Reverse relations

cites work (P2860)
Q27468917A Genome-Wide RNA Interference Screen Identifies a Role for Wnt/β-Catenin Signaling during Rift Valley Fever Virus Infection
Q47547438Anti-Rift Valley fever virus activity in vitro, pre-clinical pharmacokinetics and oral bioavailability of benzavir-2, a broad-acting antiviral compound.
Q47279983Identification of Inhibitory Compounds Against Singapore Grouper Iridovirus Infection by Cell Viability-Based Screening Assay and Droplet Digital PCR.
Q26748980Making Bunyaviruses Talk: Interrogation Tactics to Identify Host Factors Required for Infection
Q45324172Recent advances in the development of antiviral therapeutics for Rift Valley fever virus infection.
Q97519293eIF2B as a Target for Viral Evasion of PKR-Mediated Translation Inhibition

Search more.